Stan Kaye

Default user avatar

Royal Marsden NHS Foundation Trust
Room DM21
Sycamore House
Royal Marsden Hospital
Sutton
SM2 5PT
United Kingdom

Email: stan.kaye@rmh.nhs.uk
Tel: 020 8661 3539

Professor Stan Kaye is Chairman of the Section of Medicine at The Institute of Cancer Research (ICR). He also leads the Drug Development Unit at the Royal Marsden Hospital. These two roles allow Professor Kaye to take new drugs discovered in the lab and test them in clinical trials in patients. In particular, his research focuses on ovarian cancer.

More about Stan Kaye
Professor Kaye heads the Drug Development Unit at the Royal Marsden Hospital/The Institute of Cancer Research at Sutton. This is one of the largest early clinical trials units in the world, focussing entirely on Phase I trials of novel treatments for cancer.
Full scientific summary…

Recent publications


Preclinical Pharmacology, Antitumor Activity, and Development of Pharmacodynamic Markers for the Novel, Potent AKT Inhibitor CCT128930

Mol Cancer Ther.2011;10 :360-371

AT7867 Is a Potent and Oral Inhibitor of AKT and p70 S6 Kinase That Induces Pharmacodynamic Changes and Inhibits Human Tumor Xenograft Growth

Mol Cancer Ther.2010;9 :1100-1110

More publications…